YCW21· OtherEntelexo Biotherapeutics
Creating a New Class of Drugs to Address Incurable Autoimmune Diseases
ActiveChecked 16h ago
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
SFA TherapeuticsS21Regulating the immune system to block cancer & autoimmune diseasesShared: biotechActive
Parallel BioS21Using the immune system to cure diseaseShared: biotechActive
Kopra BioS24Genetically engineered viruses that teach your immune system to kill…Shared: biotechActive
Eris BiotechW24Our drugs engage the immune system to fight tumorsShared: biotechActive
AlixiaW22Targeting the Tumor Ecosystem to address cancer drug resistance.Shared: biotechActive
Also from W21
Batchmates in Winter 2021.
AbacumW21The AI-native FP&A platform that helps Finance teams drive business…Active
AlineaW21Automated investing for the next generation 💸Active
AlokaiW21Frontend Platform for eCommerceActive
AnimaW21The next generation care enablement platformActive
arnataW21AI workers for the logistics industry.Active
ArpioW21Recover from any outage in 10 minutes or less.Active
About Entelexo Biotherapeutics
Entelexo is creating modern treatments for immune-mediated diseases, such as psoriasis, using novel engineered exosome technology.
Irvine, CA, USA
Entelexo Biotherapeutics: questions
Which YC batch was Entelexo Biotherapeutics in?
Entelexo Biotherapeutics was in Y Combinator's Winter 2021 batch (W21).
Is Entelexo Biotherapeutics still active?
Y Combinator lists Entelexo Biotherapeutics as active.
Where is Entelexo Biotherapeutics based?
Entelexo Biotherapeutics lists Irvine, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.